MedCap AB (publ)

OM:MCAP Stock Report

Market Cap: SEK 7.5b

MedCap Management

Management criteria checks 4/4

MedCap's CEO is Anders Dahlberg, appointed in Nov 2020, has a tenure of 5.58 years. total yearly compensation is SEK6.06M, comprised of 51.5% salary and 48.5% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth SEK19.90M. The average tenure of the management team and the board of directors is 5.6 years and 4.1 years respectively.

Key information

Anders Dahlberg

Chief executive officer

SEK 6.1m

Total compensation

CEO salary percentage51.53%
CEO tenure5.6yrs
CEO ownership0.3%
Management average tenure5.6yrs
Board average tenure4.1yrs

Recent management updates

Analysis Article • Apr 29

Why We Think The CEO Of MedCap AB (publ) (STO:MCAP) May Soon See A Pay Rise

Key Insights MedCap to hold its Annual General Meeting on 5th of May Total pay for CEO Anders Dahlberg includes kr3.03m...

Recent updates

Analysis Article • Jan 30

Estimating The Fair Value Of MedCap AB (publ) (STO:MCAP)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedCap fair value estimate is kr577 Current share price of...
Analysis Article • Nov 06

Earnings Troubles May Signal Larger Issues for MedCap (STO:MCAP) Shareholders

MedCap AB (publ)'s ( STO:MCAP ) stock showed strength, with investors undeterred by its weak earnings report...
Analysis Article • Sep 25

Is MedCap (STO:MCAP) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Aug 28

A Look At The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Key Insights The projected fair value for MedCap is kr683 based on 2 Stage Free Cash Flow to Equity MedCap's kr621...
Analysis Article • Jul 13

MedCap AB (publ)'s (STO:MCAP) Shares Climb 27% But Its Business Is Yet to Catch Up

MedCap AB (publ) ( STO:MCAP ) shares have continued their recent momentum with a 27% gain in the last month alone. The...
Analysis Article • May 07

MedCap (STO:MCAP) Strong Profits May Be Masking Some Underlying Issues

MedCap AB (publ) ( STO:MCAP ) just released a solid earnings report, and the stock displayed some strength. Despite...
Analysis Article • May 04

Subdued Growth No Barrier To MedCap AB (publ) (STO:MCAP) With Shares Advancing 28%

MedCap AB (publ) ( STO:MCAP ) shareholders would be excited to see that the share price has had a great month, posting...
Analysis Article • Apr 29

Why We Think The CEO Of MedCap AB (publ) (STO:MCAP) May Soon See A Pay Rise

Key Insights MedCap to hold its Annual General Meeting on 5th of May Total pay for CEO Anders Dahlberg includes kr3.03m...
Analysis Article • Feb 03

Some MedCap AB (publ) (STO:MCAP) Shareholders Look For Exit As Shares Take 34% Pounding

MedCap AB (publ) ( STO:MCAP ) shareholders that were waiting for something to happen have been dealt a blow with a 34...
Analysis Article • Nov 16

We Think MedCap (STO:MCAP) Can Manage Its Debt With Ease

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Oct 18

MedCap AB (publ)'s (STO:MCAP) Earnings Haven't Escaped The Attention Of Investors

With a price-to-earnings (or "P/E") ratio of 36x MedCap AB (publ) ( STO:MCAP ) may be sending very bearish signals at...
Analysis Article • Jun 06

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Key Insights The projected fair value for MedCap is kr631 based on 2 Stage Free Cash Flow to Equity Current share price...
Analysis Article • May 21

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

The MedCap AB (publ) ( STO:MCAP ) share price has done very well over the last month, posting an excellent gain of 33...
Analysis Article • May 04

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Feb 15

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Despite an already strong run, MedCap AB (publ) ( STO:MCAP ) shares have been powering on, with a gain of 25% in the...
Analysis Article • Dec 21

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analysis Article • May 06

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Nov 23

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Sep 21

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Apr 29

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article • Feb 01

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Aug 03

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article • May 27

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

CEO Compensation Analysis

How has Anders Dahlberg's remuneration changed compared to MedCap's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

SEK 225m

Dec 31 2025SEK 6mSEK 3m

SEK 220m

Sep 30 2025n/an/a

SEK 197m

Jun 30 2025n/an/a

SEK 199m

Mar 31 2025n/an/a

SEK 202m

Dec 31 2024SEK 5mSEK 3m

SEK 207m

Sep 30 2024n/an/a

SEK 228m

Jun 30 2024n/an/a

SEK 214m

Mar 31 2024n/an/a

SEK 203m

Dec 31 2023SEK 7mSEK 3m

SEK 172m

Sep 30 2023n/an/a

SEK 150m

Jun 30 2023n/an/a

SEK 149m

Mar 31 2023n/an/a

SEK 123m

Dec 31 2022SEK 7mSEK 3m

SEK 118m

Sep 30 2022n/an/a

SEK 118m

Jun 30 2022n/an/a

SEK 107m

Mar 31 2022n/an/a

SEK 102m

Dec 31 2021SEK 6mSEK 3m

SEK 97m

Compensation vs Market: Anders's total compensation ($USD641.41K) is about average for companies of similar size in the Swedish market ($USD819.99K).

Compensation vs Earnings: Anders's compensation has been consistent with company performance over the past year.

CEO

Anders Dahlberg (50 yo)

5.6yrs
Tenure
SEK 6,055,000
Compensation

Mr. Anders Dahlberg is Chief Executive Officer of MedCap AB (publ) from November 01, 2020. He joined the MedCap AB (publ) on November 01, 2020. He was Director of Stille AB.He joined the Stille AB in 2012...

Leadership Team

NamePositionTenureCompensationOwnership
Anders Dahlberg
Chief Executive Officer5.6yrsSEK 6.06m0.27%
SEK 19.9m
Kristina Ekblad
Chief Financial Officer6.1yrsno data0.0067%
SEK 497.5k
Tove Christiansson
Business Area Head Assistive Tech11.4yrsno datano data
Anders Larnholt
Business Area Head Specialty Pharma2.7yrsno data0.027%
SEK 2.0m
Lars Ångman
Investment Managerno datano data0.033%
SEK 2.5m
5.6yrs
Average Tenure
53yo
Average Age

Experienced Management: MCAP's management team is seasoned and experienced (5.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Karl Tobieson
Chairman4.5yrsSEK 450.00k0.88%
SEK 65.5m
Lena Soderstrom
Independent Director4.1yrsSEK 185.00kno data
Otto Ankarcrona
Independent Director3.4yrsSEK 185.00kno data
David Jern
Independent Director4.5yrsSEK 185.00kno data
Malin Enarson
Independent Director3.4yrsSEK 185.00kno data
Anna Torner
Independent Director4.1yrsSEK 185.00kno data
4.1yrs
Average Tenure
54yo
Average Age

Experienced Board: MCAP's board of directors are considered experienced (4.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/11 23:32
End of Day Share Price 2026/06/11 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedCap AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Bjorn RydellABG Sundal Collier Sponsored
Hans MählerNordea Markets